Endoceutics SA
Endoceutics reported total assets of €3.45m at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Sep 2026).
The score of Endoceutics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +438 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Endoceutics's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 348,842 € | ||||
| Equity | 234,743 € | ||||
| Cash | 611,138 € | ||||
| EBITDA | 413,927 € | ||||
| Total assets | €3.45m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Sep 2026
- Year ended 31 Dec 2024filed on 14 Aug 2025
- Year ended 31 Dec 2023filed on 18 Jul 2024
- Year ended 31 Dec 2022filed on 02 May 2023
- Year ended 31 Dec 2021filed on 08 Aug 2022
Endoceutics's financial analysis
- Solvency6.8%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Endoceutics
Directors: in the full file.
Endoceutics's shareholders and holdings →Endoceutics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0715.565.040
- VAT number
- BE0715565040
- Peppol
- Registered · 0208:0715565040 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 06 Dec 2018
- Registered office
- 1040 Brussels
- Latest accounts
- 2025 · filed on 29 Sep 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Endoceutics (SA) has been based in Brussels since 2018, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 348,842 € and equity of 234,743 €; its revenue is not published. Its solvency stands at 6.8%, below the median of its sector (32.3%).
Companies similar to Endoceutics
Companies in the same business, of comparable size and area, outside its group.
- AstraZeneca Wholesale of pharmaceutical and medical goods Dilbeek · balance sheet €105.4m
- Laboratoire Colman Wholesale of pharmaceutical and medical goods La Louvière · balance sheet 42,584 €
- BIOCODEX Benelux Wholesale of pharmaceutical and medical goods Forest · balance sheet €8.15m
- Kenvue Belgium Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €32.0m
- Melisana Wholesale of pharmaceutical and medical goods Evere · balance sheet €15.4m
- Teleflex Medical Wholesale of pharmaceutical and medical goods Brussels · balance sheet €8.88m
- Laboratoires Colin Wholesale of pharmaceutical and medical goods Liège · balance sheet 343,593 €
- Livanova Belgium Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €38.8m
Frequently asked questions about Endoceutics
What is the revenue of Endoceutics?
Endoceutics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Endoceutics?
In Belgium, the VAT number is the company number prefixed with BE: BE0715565040 for Endoceutics, if the company is VAT-registered. Its company number (CBE) is 0715.565.040.
Where is the registered office of Endoceutics?
According to the CBE register, the registered office of Endoceutics is in 1040 Brussels.
What is the equity of Endoceutics?
At the close of the 2025 financial year, the equity of Endoceutics amounts to 234,743 €, a solvency of 6.8% of total assets.
The full file of Endoceutics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →